Name: | Description: | Size: | Format: | |
---|---|---|---|---|
55.08 KB | Adobe PDF |
Advisor(s)
Abstract(s)
Pathological complete response (pCR) to neoadjuvant chemotherapy (NAChT) has been validated as a predictor of long-term survival in breast cancer (BC), especially in triple-negative breast cancer (TNBC)
Description
Keywords
Citation
Publisher
Elsevier